TrialClinical trialPHN-02892026-10-21 19:00 CT
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Source · ClinicalTrials.gov: peptide AND aging
TLDR
A ClinicalTrials.gov-listed study is enrolling by invitation to assess whether geroprotective agents and a peptide-containing skin serum lower measured biological age. Researchers will use gene-activity measurements in skin and blood and assess safety and tolerability; the excerpt reports no results.
01—Key points
- 01Biological-age measurements will be compared with each participant’s baseline.
- 02Peptide-serum-treated skin areas will be compared with untreated areas on the same participant.
- 03The excerpt does not identify specific agents or peptides.
Why it matters Editorial
The study examines whether peptide-containing skin treatment and systemic geroprotective agents change aging-related measurements, without yet establishing rejuvenation benefits.
Summary generated with AI and reviewed by an editor. The original source governs; summaries can contain errors. Information only — not medical advice. Full disclaimer.
No related news yet.